Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment

BACKGROUND: One of the treatment options for type 2 diabetes mellitus (DM) is a combination drug (CD) that contains the dipeptidyl peptidase-4 inhibitor (DPP4I) alogliptin (AG) together with pioglitazone (PG). This CD can improve impaired insulin secretion and insulin resistance, which are the two m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med Res
Main Authors: Okamura, Keisuke, Shirai, Kazuyuki, Miyazaki, Motoyasu, Okuda, Tetsu, Takamiya, Yosuke, Goto, Miwa, Urata, Hidenori
Formato: Artigo
Idioma:Inglês
Publicado em: Elmer Press 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6340677/
https://ncbi.nlm.nih.gov/pubmed/30701000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados